Major Growth Driver Identified in 2025 CC Chemokine Receptor Type 5 Market: Increasing Prevalence Of Chronic Diseases On The CC Chemokine Receptor Type 5 Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

CC Chemokine Receptor Type 5 Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for the CC chemokine receptor type 5 has seen a significant expansion in the last few years. Its market value is expected to rise from $1.4 billion in 2024 to $1.55 billion in 2025, observing a compound annual growth rate (CAGR) of 10.4%. This growth surge experienced in the historical phase is a direct result of government funding contributions, collaborative R&D efforts, health awareness campaigns run by public authorities, partnerships between public and private sectors, as well as the discovery of CCR5.

CC Chemokine Receptor Type 5 Market Size Forecast: What's the Projected Valuation by 2029?
Expectations indicate that the CC chemokine receptor type 5 market will experience swift expansion in the forthcoming years, reaching up to $2.27 billion by 2029 with a compound annual growth rate (CAGR) of 10.1%. This anticipated market growth during the forecast period can be traced back to factors such as the widespread occurrence of HIV or AIDS, advancements in healthcare infrastructure, financial incentives, escalating healthcare demand, and overall economic development. The projection period is also expected to witness significant trends like the expansion of cancer research, the evolution of combination therapies, growth in pharmaceutical production, strategic alliances and partnerships, and the broadening of clinical trials.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cc-chemokine-receptor-type-5-global-market-report

What Are the Drivers Transforming the CC Chemokine Receptor Type 5 Market?
The rise in chronic diseases is anticipated to fuel the expansion of the CC chemokine receptor type 5 market. Chronic diseases are long-lasting medical conditions like heart disease, diabetes, and arthritis, which worsen slowly and usually necessitate ongoing treatment. Growing elderly populations and an increase in lifestyle-related risk factors like unhealthy diets, lack of exercise, and obesity are leading to increased cases of chronic diseases. The CC Chemokine Receptor Type 5 (CCR5) is vital in chronic diseases like HIV as it functions as a coreceptor allowing the virus to penetrate and infect immune cells, thereby playing an essential role in the disease's progression. For instance, the Joint United Nations Programme on HIV/AIDS, a comprehensive global program based in Switzerland working towards the prevention of HIV, reported in October 2023, that the number of people suffering from HIV surged from 38.7 million in 2021 to 39.0 million in 2022, with 1.3 million new infections in 2022. This rise in chronic diseases, hence, is contributing to the growth of the CC chemokine receptor type 5 market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18290&type=smp

What Long-Term Trends Will Define the Future of the CC Chemokine Receptor Type 5 Market?
Major players in the CC chemokine receptor type 5 market are strategizing to gain a competitive edge by focusing on the creation of innovative drugs such as a CCR5 antagonist. The CCR5 antagonist is a drug type that inhibits the CC chemokine receptor type 5 (CCR5) on immune cells, blocking pathogens like HIV from associating and penetrating these cells, which moderates immune responses and prevents infection. For instance, in February 2024, CytoDyn Inc., an American biotechnology company, disclosed that the U.S. Food and Drug Administration (FDA) had cleared the clinical hold on leronlimab. The corporation is now allowed to proceed with its scheduled HIV clinical trial to analyze the effect of leronlimab on chronic inflammation. Known as PRO 140, Leronlimab is a CCR5 antagonist and is showing potential in several therapeutic uses due to its capability to target many health issues. It is currently under evaluation for several indications including HIV and cancer.

Which Segments in the CC Chemokine Receptor Type 5 Market Offer the Most Profit Potential?
The CC chemokine receptor type 5 market covered in this report is segmented -

1) By Type: BMS-813160, AG-1105, CCL-14, DS-001, Other Types
2) By Distribution Channel: Hospitals, Clinics, Online Pharmacies, Retail Pharmacies
3) By Application: Infectious Disease, Gastrointestinal, Immunology, Oncology, Other Applications
4) By End User: Research Institutes, Pharmaceutical Companies, Healthcare Facilities

Subsegments:
1) By BMS-813160: CCR5 Antagonist For HIV Treatment, CCR5 Antagonist For Inflammatory Diseases
2) By AG-1105: CCR5 Antagonist For Autoimmune Disorders, CCR5 Antagonist For Cancer Therapy
3) By CCL-14: Chemokine Ligand For Targeted Therapy, CCL-14 For Immune Modulation
4) By DS-001: CCR5 Inhibitor For Cancer Treatment, DS-001 For Inflammatory Disease Management
5) By Other Types: Novel CCR5 Antagonists, Dual-Target CCR5 Antagonists

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18290&type=smp

Which Firms Dominate the CC Chemokine Receptor Type 5 Market by Market Share and Revenue in 2025?
Major companies operating in the cc chemokine receptor type 5 market are Pfizer Inc., Sorrento Therapeutics, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Avexa Limited, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical, Gilead Sciences Inc., Vertex Pharmaceuticals, Ono Pharmaceutical Co Ltd, Abcam Limited, BioLegend Inc., R&D Systems Inc, American Gene Technologies International Inc, NSJ Bioreagents, Cytodyn Inc., Affinity Biosciences

Which Regions Offer the Highest Growth Potential in the CC Chemokine Receptor Type 5 Market?
North America was the largest region in the CC chemokine receptor type 5 market in 2024. The regions covered in the CC chemokine receptor type 5 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18290

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.